PHYSIOLOGICAL EFFECTS OF DRUGS
Clinical trials for PHYSIOLOGICAL EFFECTS OF DRUGS explained in plain language.
Never miss a new study
Get alerted when new PHYSIOLOGICAL EFFECTS OF DRUGS trials appear
Sign up with your email to follow new studies for PHYSIOLOGICAL EFFECTS OF DRUGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a targeted drug delay prostate cancer progression?
Disease control OngoingThis phase 3 trial tests whether adding the targeted drug abemaciclib to standard hormone therapy (abiraterone plus prednisone) can delay cancer growth in men with high-risk prostate cancer that has spread to bones or organs. Participants receive either abemaciclib or a placebo a…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New injection could smooth away neck bands
Symptom relief OngoingThis phase 3 trial tests whether NT 201 (a botulinum toxin injection) can safely reduce the appearance of moderate to severe neck bands (platysma prominence) in adults. About 300 participants in Europe will receive either NT 201 or a placebo injection. The study measures improvem…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New injection could smooth neck bands in phase 3 trial
Symptom relief OngoingThis phase 3 trial tests whether NT 201 (incobotulinumtoxinA, a botulinum toxin type A injection) can safely reduce the appearance of moderate to severe neck bands (platysma prominence) compared to a placebo. About 300 adults in the US are participating in this double-blind study…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE3 • Sponsor: Merz North America, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC